Академический Документы
Профессиональный Документы
Культура Документы
Meyer
Method
Words: 1195
Luke Meyer
Databases such as FIndIt@Flinders, Google Scholar, Proquest and Taylor & Francis Online
where used to locate information. Key words such as sport in society, drugs in sport,
performance enhancing, anabolic steroids, creatine, blood doping, health risks,
ethics and legalization were used in searches in previously mentioned databases and
journals including Sport in Society: Cultures, Commerce, Media, Politics and The
International Journal of the History of Sport. Searches in databases were also refined by
limiting the resource type to peer-reviewed journal articles and using articles post the year
2000, showing relevance. Flinders Central Library was also used to locate useful materials.
Body
Health Risks
Anabolic steroids are taken by athletes to enhance performance, increase muscle size and
decrease body fat (Chyka, 2003). Although they have a distinct positive Chyka (2003) states
that they can result in negative side effects. According to Chyka (2003) Effects include short
stature with childhood use, tendon rupture, left ventricular hypertrophy, liver tumours, HIV/
AIDS and hepatitis. Infertility, breast development and a high-pitched voice are male
related health risks while excessive growth of body hair and a low-pitched voice are female
Chyka (2003).
Creatine in its phosphylated form, phosphocreatine, is used in muscle cells to generate ATP
from ADP (Chyka, 2003). Supplementation of creatine monohydrate increases the
availability phosphocreatine in the production of ATP during anaerobic exercise and
promotes the aerobic resynthesis of phosphocreatine during recovery (Chyka, 2003).
Accoding to Chyka (2003) health risks of creatine include the retention of creatine in tissues,
the reduction of urine production, muscle enlargement due to water absorption and
massive onset weight gain from water retention.
Blood doping is used to increase the amount of oxygen in the blood by blood transfusion
into the circulatory system (Towns & Gerrard, 2014). Therefore, this increases an athletes
aerobic capacity. According to Towns and Gerrard (2014) bacterial contamination and viral
transmission are too ways in which disease can be transferred. HIV/ AIDS, the most common
Words: 1195
Luke Meyer
transfusion transmitted infection can also be transmitted though blood doping (Towns &
Gerrard, 2014).
Athletes Motives for Use
Despite the inability to reliably measure the incidence of performance enhancing drug use it
can be wildly recognised that PED use is an issue. Athletes are repeatedly motivated by
profit (Connor, 2009; Ehrnborg & Rosn, 2009) and the idea that everyone else is using
PEDs (Ehrnborg & Rosn, 2009). If athletes take PEDs their performance will increase and
therefore their chances of winning will increase. According to Connor (2009) winning leads
to contracts, media coverage, sponsorship, government support and prize money. Connor
(2009) states that the desire to win and make profit can override moral obligations and
possible consequences. Many athletes are also motivated by the fact that other competitors
are using performance enhancing drugs (Ehrnborg & Rosn, 2009). According to Ehrnborg
and Rosn this phenomenon is referred to as the doping dilemma. Even if athletes do not
use PEDs but there is a perception of PED use, it can ignite the desire of the athletes to
conform to the psychological pressure and use PEDs.
Discussion on Legalization
Words: 1195
Luke Meyer
Conclusion
This literature review has discussed the health risks for different performance enhancing
drugs as they are important to note as there is a prevalence of PEDs, the incidence of PED
use and suggests that the perceived incidence may be more prevalent than the actual
incidence, the motivation that athletes have for PED use including the profit motive and the
doping dilemma and some reasons to legalize and prohibit future PED use. As the actual
incidence of PEDs is unclear more research needs to be done to increase the accuracy of its
use in sport. This would then affect the perceived incidence and in turn the doping
dilemma, as stated by Ehrnborg Rosn (2009), may be minimized. Both sides of the
legalization argument present valid points and consider moral obligations and practical
benefits, but in the future the decision has to be made with great care as it will
detrimentally effect the way sport is performed and our opinions of it.
Words: 1195
Luke Meyer
References
Chyka, P. A. (2003). Health Risks of Selected Performance-Enhancing Drugs. Journal of Pharmacy
Practise, 16, 37-44. doi: 10.1177/0897190002239631
Connor, J. M. (2009). Towards a sociology of drugs in sport. Sport in Society: Cultures, Commerce,
Media, Politics, 12(3), 327-328. doi:10.1080/17430430802673676
Craciun, M., Siserman, C., Petrehu, D., Grosu, E. F., Dobo, S. (2011). Ethical Issues in Sport
Performance Enhancement. Romanian Journal of Bioethics, 9(3), 98-109. Retrieved from
http://search.proquest.com.ezproxy.flinders.edu.au/docview/1286689556?accountid=10910
Ehrnborg, C., Rosn, T. (2009). The psychology behind doping in sport. Hormone & IGF Research,
19(4), 285-287. doi:10.1016/j.ghir.2009.04.03
Holt, R. I., Erotokritou-Mulligan, I., & Snksen, P. H. (2009) The history of doping and growth
hormone abuse in sport. Growth Hormone & IGF Research, 19(4), 320-326.
doi:http://dx.doi.org/10.1016/j.ghir.2009.04.009
Kayser, B., Mauron, A., & Miah, A. (2005). Viewpoint: Legalisation of performance-enhancing drugs.
The Lancet, 366, 1. Retrieved from
http://search.proquest.com.ezproxy.flinders.edu.au/docview/199046529?accountid=10910
Kolt, G. S. (2012). Drugs in sport: Do we have what it takes to beat the battle?. Journal of Science and
Medicine in Sport, 15(5). Retrieved from
http://search.proquest.com.ezproxy.flinders.edu.au/docview/1041253767?accountid=10910
Lentillon-Kaestner, V., Ohl, F. (2010). Can we measure accurately the prevalence of doping?.
Scandinavian Journal of Medicine & Science in Sports, 21(6), 132-142. doi: 10.1111/j.16000838.2010.01199.x
Moston, S., Engelberg, T., & James Skinner (2015). Perceived incidence of drug use in Australian
sport: a survey of athletes and coaches. Sport in Society, 18(1). 91-105, doi:
10.1080/17430437.2014.927867
Murray, T. H. (2008). Doping in sport: challenges for medicine, science and ethics. Journal of Internal
Medicine, 264, 95-98. doi: 10.1111/j.1365-2796.2008.01994.x
Words: 1195
Luke Meyer
Park, J. (2005). Governing Doped Bodies: The World Anti-Doping Agency and the Global Culture of
Surveillance. Cultural Studies <--> Critical Methodologies, 5(2), 174-188.
doi:10.1177/1532708605274945
Sottas, P. E., Robinson, N., Fischetto, G., Doll, G., Alonso, J. M. (2011). Prevalence of Blood Doping
in Samples Collected from Elite Track and Field Athletes. Clinical Chemistry, 57(5), 762-769.
Retrieved from
http://search.proquest.com.ezproxy.flinders.edu.au/docview/865356955?accountid=10910
Towns, C. R., Gerrard, D. F. (2014). A fool's game: Blood doping in sport. Performance Enhancement
& Health, 3(1), 54-58. doi:10.1016/j.peh.2014.11.001
Whitman, J. H. (2008). Winning at All Costs: Using Law &(and) Economics to Determine the Proper
Role of Government in Regulating the Use of Performance-Enhancing Drugs in Professional Sports.
University of Illinois Law Review, 459. Retrieved from
http://heinonline.org.ezproxy.flinders.edu.au/HOL/Page?public=false&handle=hein.journals/unilllr2
008&page=459&collection=journals#
Words: 1195